How does MOLN's 2021 EPS compare to 2020?
4/7/2025 05:16pm
Molecular Partners (MOLN) reported a significant improvement in its EPS from 2020 to 2021, with the diluted EPS decreasing from $-2.84 in 2020 to $-2.25 in 2021, representing a positive change of 4.05%. This indicates a reduction in the company's losses per share, suggesting improved financial performance and potential recovery or stabilization in the company's financial health.
|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|MOLN|MOLN.O|Molecular Partners|2020 Q1||-0.644022024|185|
|MOLN|MOLN.O|Molecular Partners|2021 Q1|6.024325776784299|-0.6052240392|185|
|MOLN|MOLN.O|Molecular Partners|2021 Q3||-0.4068958148|185|